Advertisement
Advertisement

SGHT

SGHT logo

Sight Sciences, Inc. Common Stock

5.38
USD
Sponsored
+0.09
+1.70%
May 08, 15:58 UTC -4
Closed
exchange

After-Market

5.38

0.00
0.00%

SGHT Earnings Reports

Positive Surprise Ratio

SGHT beat 13 of 20 last estimates.

65%

Next Report

Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
$21.77M
/
-$0.15
Implied change from Q1 26 (Revenue/ EPS)
+10.50%
/
-6.25%
Implied change from Q2 25 (Revenue/ EPS)
+11.27%
/
-34.78%

Sight Sciences, Inc. Common Stock earnings per share and revenue

On May 06, 2026, SGHT reported earnings of -0.16 USD per share (EPS) for Q1 26, beating the estimate of -0.16 USD, resulting in a 5.10% surprise. Revenue reached 19.70 million, compared to an expected 18.92 million, with a 4.15% difference. The market reacted with a +23.02% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 9 analysts forecast an EPS of -0.15 USD, with revenue projected to reach 21.77 million USD, implying an decrease of -6.25% EPS, and increase of 10.50% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Artivion, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.05
Actual
$0.08
Surprise
+59.68%
logo
Tandem Diabetes Care, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.45
Actual
-$0.30
Surprise
+34.01%
logo
Pacific Biosciences of California, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.13
Actual
-$0.12
Surprise
+12.73%
logo
Delcath Systems Inc
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.08
Actual
-$0.03
Surprise
+66.06%
logo
EDAP TMS SA
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.19
Actual
-$0.24
Surprise
-25.59%
logo
Treace Medical Concepts, Inc. Common Stock
Report Date
May 08, 2026 For Q1 26
Estimate
-$0.31
Actual
-$0.28
Surprise
+10.88%
logo
Sensus Healthcare, Inc
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.12
Actual
-$0.16
Surprise
-25.49%
logo
LENSAR, Inc. Common Stock
Report Date
May 08, 2026 For Q1 26
Estimate
$0.18
Actual
$0.00
Surprise
-100.00%
logo
Mettler-Toledo International
Report Date
May 07, 2026 For Q1 26
Estimate
$8.78
Actual
$8.91
Surprise
+1.37%
logo
GLOBUS MEDICAL INC
Report Date
May 07, 2026 For Q1 26
Estimate
$0.93
Actual
$1.12
Surprise
+19.39%
FAQ
For Q1 2026, Sight Sciences, Inc. Common Stock reported EPS of -$0.16, beating estimates by 5.1%, and revenue of $19.70M, 4.15% above expectations.
The stock price moved up 23.02%, changed from $4.30 before the earnings release to $5.29 the day after.
The next earning report is scheduled for Aug 05, 2026.
Based on 9 analysts, Sight Sciences, Inc. Common Stock is expected to report EPS of -$0.15 and revenue of $21.77M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement